Over 600 women have now been recruited to this study, which monitors and collects samples from women from week 12 of their first pregnancy and follows their development through to birth.
At each point, the maternal fatty acid, metabolomic and lipidomic profiles will be investigated, harnessing discovery science to accurately phenotype different profiles of women.
The study will help us identify potential diagnostic markers of risk and develop predictive algorithms with which to screen all women in early pregnancy and, potentially, before conception.